$3.19
-0.11-3.33%
In chiusura: -
$3.14
-0.05-1.57%
After hour: Oct 10, 5:18 PM EDT
Maravai LifeSciences segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Maravai LifeSciences utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
MRVI | Maravai LifeSciences | -$0.02 | -$0.08 | — | — | $65.20M | $49.88M | — | — | 11/06/2025 | |
MRVI | Maravai LifeSciences | $0.00 | -$0.08 | -$0.08 | 0.00% | $73.40M | $47.81M | $47.40M | -0.87% | 08/11/2025 | |
MRVI | Maravai LifeSciences | -$0.02 | -$0.07 | -$0.08 | -14.29% | $64.18M | $44.01M | $46.85M | 6.45% | 05/12/2025 | |
MRVI | Maravai LifeSciences | $0.01 | -$0.04 | -$0.06 | -50.00% | $74.14M | $57.79M | $56.56M | -2.13% | 03/18/2025 | |
MRVI | Maravai LifeSciences | -$0.01 | -$0.01 | -$0.02 | -100.00% | $66.86M | $67.55M | $65.20M | -3.48% | 11/07/2024 | |
MRVI | Maravai LifeSciences | $0.00 | $0.00 | $0.00 | — | $68.91M | $71.63M | $73.40M | 2.47% | 08/07/2024 | |
MRVI | Maravai LifeSciences | $0.03 | -$0.03 | -$0.02 | 33.33% | $79.03M | $60.55M | $64.18M | 5.99% | 05/08/2024 | |
MRVI | Maravai LifeSciences | $0.35 | -$0.01 | $0.01 | 200.00% | $204.71M | $64.38M | $74.14M | 15.16% | 02/22/2024 | |
MRVI | Maravai LifeSciences | $0.37 | $0.01 | -$0.01 | -200.00% | $191.26M | $75.52M | $66.86M | -11.46% | 11/07/2023 | |
MRVI | Maravai LifeSciences | $0.54 | $0.01 | $0.00 | -100.00% | $242.73M | $70.30M | $68.91M | -1.97% | 08/07/2023 | |
MRVI | Maravai LifeSciences | $0.54 | $0.04 | $0.03 | -25.00% | $244.29M | $79.72M | $79.03M | -0.87% | 05/08/2023 | |
MRVI | Maravai LifeSciences | $0.45 | $0.34 | $0.35 | 2.94% | $228.44M | $204.93M | $204.71M | -0.11% | 02/22/2023 | |
MRVI | Maravai LifeSciences | $0.44 | $0.33 | $0.37 | 12.12% | $204.81M | $195.10M | $191.26M | -1.97% | 11/02/2022 | |
MRVI | Maravai LifeSciences | $0.44 | $0.45 | $0.54 | 20.00% | $217.78M | $233.24M | $242.73M | 4.07% | 08/04/2022 | |
MRVI | Maravai LifeSciences | $0.26 | $0.44 | $0.54 | 22.73% | $148.21M | $232.30M | $244.29M | 5.16% | 05/05/2022 | |
MRVI | Maravai LifeSciences | $0.13 | $0.38 | $0.45 | 18.42% | $98.35M | $208.09M | $228.44M | 9.78% | 02/23/2022 | |
MRVI | Maravai LifeSciences | — | $0.35 | $0.44 | 25.71% | — | $201.50M | $204.81M | 1.64% | 11/10/2021 | |
MRVI | Maravai LifeSciences | — | $0.31 | $0.44 | 41.94% | — | $192.29M | $217.78M | 13.25% | 08/10/2021 | |
MRVI | Maravai LifeSciences | — | $0.20 | $0.26 | 30.00% | $50.98M | $138.49M | $148.21M | 7.02% | 05/10/2021 | |
MRVI | Maravai LifeSciences | — | $0.11 | $0.13 | 18.18% | — | $89.02M | $98.35M | 10.48% | 03/02/2021 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-11 | $-0.08 | $-0.08 | 0.00 % |
Q1 | 2025-05-12 | $-0.08 | $-0.07 | -14.3 % |
Q4 | 2025-03-18 | $-0.06 | $-0.04 | -50.0 % |
Q3 | 2024-11-07 | $-0.02 | $-0.01 | -100.0 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-11 | $47.40M | $47.81M | -0.87 % |
Q1 | 2025-05-12 | $46.85M | $44.01M | 6.45 % |
Q4 | 2025-03-18 | $56.56M | $57.79M | -2.13 % |
Q3 | 2024-11-07 | $65.20M | $67.55M | -3.48 % |
Si prevede che Maravai LifeSciences (MRVI) fornisca risultati il novembre 6, 2025. Gli ultimi risultati sono stati pubblicati il agosto 11, 2025 per il Q2.
L'EPS effettivo era $-0.08, che centrato la stima di $-0.08.
Le entrate effettive sono state $47.4M, che mancato la stima di $47.8M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.